ABOS · NASDAQ · Healthcare · $15.2M· Short % 6.1%
$0.21close of 2026-10-30 · not real-time
💰 Net stock buybacks last fiscal year: $73,000 · 0.48% of market cap
⚠ Value-trap warning
This stock is flagged by our value-trap filter (e.g. shrinking earnings, negative free cash flow, or losses). Cheap can stay cheap — read why before acting.
Which value-trap type
vs. analyst consensus target. The target is an opinion, not a prediction or buy signal. Large gap — low confidence.
Some axes lack data (–)
A summary of valuation factors — not a buy recommendation. You decide.
| Company | PER | PBR | ROE | Div | Score |
|---|---|---|---|---|---|
| Acumen Pharmaceuticals Inc. | – | 0.4 | -163% | 0.0% | 35 |
| Nortech Systems Incorporated | 28.1 | 0.8 | 3% | 0.0% | 53 |
| Precipio Inc. | – | 2.2 | -9% | 0.0% | 43 |
| Harvard Bioscience Inc. | – | 5.5 | -90% | 0.0% | 50 |
| Davion Healthcare Plc | – | 0.6 | -1% | 0.0% | – |
| GridAI Technologies Corp. | – | – | – | 0.0% | 35 |
Same sector, nearest by market cap · – = no data (value traps excluded)
Chart patterns matched (observational)
Technical patterns for reference — not a buy recommendation.
Open-market buys & sells by this company's officers & directors (SEC Form 4)
Observational — buy/sell facts only, not a recommendation. Filing dates (the trade was 1–2 business days earlier). Routine comp (option exercises, grants) excluded — discretionary buys/sells only.
The chart (long-term trend, Ichimoku cloud) is for observation only — not a buy or sell signal.
A highlight of the key metrics detailed below.
Top-tier in 0 of 2 evaluated strategies
Ranks within the US market — tap to open that ranking (ranks are per market).
Past returns — they do not guarantee future results.
Color: green = healthy, red = caution (absolute thresholds, value/quality metrics only). Downside vol & Sortino are annualized. Max drawdown = largest drop from a 3-year peak; volatility = 1-year annualized. Price/Graham < 1 = below Graham fair value (profitable, positive-equity names only). RSI < 30 = oversold. For reference only.
A Japanese trend tool. Price above the 'cloud' is supportive; below is weak. A strong uptrend doesn't mean it's cheap — stocks that have run up are usually more expensive.